Despite appearances, lean individuals can develop non-alcoholic fatty liver disease (NAFLD), now known as metabolic ...

As rates of MASLD, which is linked to obesity and diabetes, rise, new therapies have emerged, but better diagnostic and ...

A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting ...

Researchers assess the ability of the Risk Estimation of Tumor REcurrence After Transplant score to predict recurrence of hepatocellular carcinoma in patients who underwent liver transplants as a ...

A novel molecular imaging agent targeting glypican-3 (GPC3) has demonstrated high sensitivity and specificity in detecting ...

Discover a study where results suggest that while MASLD is common in patients with T2DM in primary care, advanced liver ...

In summary, the study shows that fatty liver is very common in people with type 2 diabetes, especially when obesity is also ...

Six out of ten people with type 2 diabetes had fatty liver in a new study from Linköping University in Sweden. Of these, only ...

In addition to being faster and less invasive than a traditional tissue biopsy, the blood test is also potentially more ...

Consistent with its revamped go-to-market strategy, ENDRA is conducting a multisite clinical initiative designed to bolster the diagnostic performance of TAEUS Liver prior to initiation of the FDA ...